important announcement:
Wanhua Chemical Group Co.Ltd(600309) : net profit in 2021 increased by 145.47% year on year
Luxshare Precision Industry Co.Ltd(002475) : net profit in 2021 decreased by 2.12% year on year
Ganfeng Lithium Co.Ltd(002460) : net profit in 2021 increased by 405.03% year on year
Linewell Software Co.Ltd(603636) : electronic license projects account for a relatively small proportion of the company’s revenue
Nanjing Vazyme Biotech Co.Ltd(688105) : the impact of New Coronavirus antigen detection kit on the company’s performance is not yet able to predict.
Ningbo Jintian Copper (Group) Co.Ltd(601609) : it is proposed to repurchase shares of RMB 150 million to RMB 300 million
Shanghai stock exchange important announcement:
Ningbo Jintian Copper (Group) Co.Ltd(601609) : it is proposed to repurchase shares of RMB 150 million to RMB 300 million
Ningbo Jintian Copper (Group) Co.Ltd(601609) ( Ningbo Jintian Copper (Group) Co.Ltd(601609) ) announcement: the company plans to repurchase shares with 150300 million yuan, and the repurchase price shall not exceed 12.65 yuan / share. The shares repurchased this time will be used for equity incentive or employee stock ownership plan.
Shanghai Zhonggu Logistics Co.Ltd(603565) : from January to February, the net profit increased by about 108% year-on-year
Shanghai Zhonggu Logistics Co.Ltd(603565) ( Shanghai Zhonggu Logistics Co.Ltd(603565) ) announcement: according to the company’s preliminary accounting, from January to February 2022, the company achieved a total operating revenue of about 2 billion yuan, an increase of about 13% year-on-year; The net profit attributable to the shareholders of the listed company was about 464 million yuan, a year-on-year increase of about 108%.
Liaoning Port Co.Ltd(601880) : from January to February, the operation of direct China Europe trains at Dalian port increased by 80% year-on-year
Liaoning Port Co.Ltd(601880) ( Liaoning Port Co.Ltd(601880) ) announcement: after preliminary accounting, from January to February 2022, Dalian port opened 18 direct China Europe trains with nearly 1900 TEUs, an increase of 80% and 69% respectively year-on-year. The goods radiate to the southeast coastal ports, mainly electronic equipment, household appliances, daily necessities, auto parts, etc.
Anhui Gourgen Traffic Construction Co.Ltd(603815) : won the bid for 740 million yuan Expressway Subgrade and pavement construction project
Anhui Gourgen Traffic Construction Co.Ltd(603815) ( Anhui Gourgen Traffic Construction Co.Ltd(603815) ) announcement: the company won the bid for Subgrade and pavement construction-6 bid section of Hefei section of Chuzhou Hefei Zhoukou expressway, with a bid winning amount of 740 million yuan, accounting for 23.29% of the company’s audited operating revenue in 2020.
Hebei Hengshui Laobaigan Liquor Co.Ltd(600559) : the net profit from January to February increased by about 680% year-on-year
Hebei Hengshui Laobaigan Liquor Co.Ltd(600559) ( Hebei Hengshui Laobaigan Liquor Co.Ltd(600559) ) announcement: during the Spring Festival in 2022, the sales of the company’s products increased well. According to the preliminary accounting of the company, from January to February 2022, the company achieved a total operating revenue of about 708 million yuan, a year-on-year increase of about 10%; The net profit after deducting non recurring profits and losses was about 40 million yuan, with a year-on-year increase of about 23%. The net profit attributable to the shareholders of the listed company was about 220 million yuan, with a year-on-year increase of about 680%. The net profit attributable to the shareholders of the listed company increased significantly, mainly because the company received land collection and storage compensation in January 2022, and the company included the relevant income of the above land compensation into non recurring profits and losses, As a result, the non recurring profit and loss from January to February 2022 increased by about 180 million yuan compared with January to February 2021.
Sichuan Hebang Biotechnology Co.Ltd(603077) : it is proposed to spin off its subsidiary Wujun Guangneng and list on the main board of Shanghai Stock Exchange
Sichuan Hebang Biotechnology Co.Ltd(603077) ( Sichuan Hebang Biotechnology Co.Ltd(603077) ) announcement: the company plans to spin off its subsidiary, Sichuan Wujun Guangneng Co., Ltd. (hereinafter referred to as “Wujun Guangneng”) to be listed on the main board of Shanghai Stock Exchange. After the completion of this spin off, the equity structure of the company will not change, and still has the controlling interest in Wujun Guangneng.
Nanjing Vazyme Biotech Co.Ltd(688105) : the impact of New Coronavirus antigen detection kit on the company’s performance is not yet able to predict.
Nanjing Vazyme Biotech Co.Ltd(688105) ( Nanjing Vazyme Biotech Co.Ltd(688105) ) announcement: the company issued the announcement of abnormal fluctuation in stock trading. The New Coronavirus antigen detection kit produced by Nanjing Vazyme Biotech Co.Ltd(688105) , a wholly owned subsidiary, has recently obtained the “medical device registration certificate” issued by the State Administration of drug control, and has completed the expected use of medical device product registration, increased the sample type and the changes in the contents of the manual. The sales of the above products are affected by many factors, such as national epidemic prevention and control and procurement policies, testing needs, covid-19 epidemic changes and so on. At the same time, they may face the risk of fierce market competition, and the continuous impact on the company’s future performance cannot be specifically predicted.
Zhongxing Tianheng Energy Technology (Beijing)Co.Ltd(600856) : the suspension verification is completed, and the trading of shares will resume from the opening of the market on March 15
Zhongxing Tianheng Energy Technology (Beijing)Co.Ltd(600856) ( Zhongxing Tianheng Energy Technology (Beijing)Co.Ltd(600856) ) announcement: the company has conducted necessary verification on matters related to stock trading fluctuations. In view of the completion of relevant verification work, upon the application of the company, the trading of the company’s shares will resume from the opening of the market on March 15.
Shandong Fiberglass Group Co.Ltd(605006) : profit from January to February increased by about 27% year-on-year
Shandong Fiberglass Group Co.Ltd(605006) ( Shandong Fiberglass Group Co.Ltd(605006) ) announcement: according to the preliminary accounting of the company, from January to February 2022, the company realized an operating revenue of about 570 million yuan, an increase of about 12% over the same period last year; The total profit was about 150 million yuan, an increase of about 27% over the same period last year. From January to February, the high prosperity situation of the glass fiber industry continued, and the market demand for glass fiber products at home and abroad was strong, especially in the overseas market. The company’s convertible bond raised investment project – high-end glass fiber manufacturing project 3 production line with an annual output of 100000 tons reached production ahead of schedule, and the production and sales of glass fiber yarn were balanced.
Linewell Software Co.Ltd(603636) : electronic license projects account for a relatively small proportion of the company’s revenue
Linewell Software Co.Ltd(603636) ( Linewell Software Co.Ltd(603636) ) announcement: the company is concerned about media reports that the company is involved in electronic license business. In 2020, the proportion of electronic license projects in the annual operating revenue of the company is relatively small, which does not have a significant impact on the production and operation of the company.
China Meheco Group Co.Ltd(600056) : covid-19 virus treatment drug related business has no significant impact on the company’s recent operating performance
China Meheco Group Co.Ltd(600056) ( China Meheco Group Co.Ltd(600056) ) announcement: the company signed an agreement with Pfizer Inc in March 9, 2022 to be responsible for the commercial operation of Pfizer Inc COVID-19 virus treatment PAXLOVID in Chinese mainland market during the agreement period (2022). This product is a prescription drug, which has not yet entered the national medical insurance and China covid-19 pneumonia diagnosis and treatment plan. The final use and sales are affected by epidemic prevention and control and other factors, and it is expected that the relevant business scale accounts for a small proportion of the company’s overall business volume, which has no significant impact on the company’s recent operating performance.
Thalys Medical Technology Group Corporation(603716) : the controlling shareholder intends to introduce strategic investors through agreement transfer
Thalys Medical Technology Group Corporation(603716) ( Thalys Medical Technology Group Corporation(603716) ) announcement: saihai technology, the controlling shareholder of the company, plans to introduce strategic investors and improve the corporate governance structure through agreement transfer; The New Coronavirus antigen detection kit developed by the company has been applied but has not yet obtained the medical device registration certificate issued by the China National Drug Administration, and is not yet available for sale in China.
2021 annual report:
Wanhua Chemical Group Co.Ltd(600309) : net profit in 2021 increased by 145.47% year on year
Wanhua Chemical Group Co.Ltd(600309) ( Wanhua Chemical Group Co.Ltd(600309) ) announcement: the operating revenue in 2021 was 145538 billion yuan, a year-on-year increase of 98.19%; The net profit was 24.649 billion yuan, a year-on-year increase of 145.47%; The basic earnings per share is 7.85 yuan. It is proposed to pay a cash dividend of 25 yuan (including tax) for every 10 shares.
Annual performance report:
Anhui Kouzi Distillery Co.Ltd(603589) : net profit in 2021 increased by 35.37% year on year
Anhui Kouzi Distillery Co.Ltd(603589) ( Anhui Kouzi Distillery Co.Ltd(603589) ) announcement: the operating revenue in 2021 was 5.029 billion yuan, with a year-on-year increase of 25.37%; The net profit attributable to the parent company was 1.727 billion yuan, a year-on-year increase of 35.37%; The basic earnings per share is 2.88 yuan.
HuaSu Co., Ltd.: net profit in 2021 increased by 27.77% year-on-year
HuaSu Co., Ltd. (600935) announced that the operating revenue in 2021 was 6.739 billion yuan, a year-on-year increase of 32.65%; The net profit attributable to the parent company was 784 million yuan, a year-on-year increase of 27.77%; The basic earnings per share is 0.25 yuan.
Shenzhen important announcement:
Netac Technology Co.Ltd(300042) : Shiyan plant temporarily stopped production affected by the epidemic
Netac Technology Co.Ltd(300042) ( Netac Technology Co.Ltd(300042) ) announcement: the company responded positively to the government’s epidemic prevention policy. According to the announcement, the company temporarily stopped production in Shiyan factory on March 14, and all employees worked at home to fully cooperate with the government’s epidemic prevention work to curb the spread of the epidemic. The specific time for resuming normal production and operation will be arranged according to the government’s epidemic control requirements.
Power investment and energy: from January to February, the net profit increased by about 80.19% year-on-year
Announcement of power investment energy ( Huolinhe Opencut Coal Industry Corporation Limited Of Inner Mongolia(002128) ): according to the preliminary accounting of the company, from January to February 2022, the company achieved an operating revenue of about 4.737 billion yuan, a year-on-year increase of about 25.79%; The net profit attributable to shareholders of listed companies was about 1.026 billion yuan, with a year-on-year increase of about 80.19%.
Ganfeng Lithium Co.Ltd(002460) : the net profit from January to February increased by about 300% year-on-year
Ganfeng Lithium Co.Ltd(002460) ( Ganfeng Lithium Co.Ltd(002460) ) announcement: the company’s operation was stable from January to February 2022, the product price further increased, and the sales volume increased year-on-year. According to the preliminary accounting of the company, from January to February 2022, the company achieved an operating revenue of about 3.6 billion yuan, with a year-on-year increase of about 260%; The net profit attributable to the shareholders of the listed company was about 1.4 billion yuan, an increase of about 300% year-on-year; After deducting non recurring profits and losses, the net profit attributable to shareholders of listed companies was about 1.8 billion yuan, an increase of about 1000% year-on-year.
Jiangsu Chuanzhiboke Education Technology Co.Ltd(003032) : it is proposed to repurchase shares with 30 million yuan to 60 million yuan
Jiangsu Chuanzhiboke Education Technology Co.Ltd(003032) ( Jiangsu Chuanzhiboke Education Technology Co.Ltd(003032) ) announcement: the company plans to use its own funds to buy back some RMB common shares issued by the company in China in the form of centralized bidding transaction for the later implementation of employee stock ownership plan or equity incentive. The total amount of funds to be used for repurchase shall not be less than 30 million yuan and not more than 60 million yuan, and the repurchase price shall not exceed 25.00 yuan / share.
Dongguan Kingsun Optoelectronic Co.Ltd(002638) : it is proposed to sell two subsidiaries in the education and training industry
Dongguan Kingsun Optoelectronic Co.Ltd(002638) ( Dongguan Kingsun Optoelectronic Co.Ltd(002638) ) announcement: in order to implement the “double reduction policy”, safeguard the rights and interests of listed companies, protect the interests of all shareholders of the company, realize the adjustment of the company’s education and training related business as soon as possible and avoid the risks in the education and training industry, after careful consideration by the board of directors, it is proposed to transfer 100% equity of Guangzhou Longwen, a subsidiary of the company in the education and training industry 99% equity of Beijing longwenyun was transferred to Zhuhai Huizhuo at a consideration of 1 yuan. After the equity transfer, Guangzhou Longwen and Beijing longwenyun will no longer be included in the scope of the company’s consolidated statements.
Winning Health Technology Group Co.Ltd(300253) : it is proposed to repurchase shares with RMB 100 million to RMB 150 million
Winning Health Technology Group Co.Ltd(300253) ( Winning Health Technology Group Co.Ltd(300253) ) announcement: the company plans to use its own funds to buy back the company’s shares by means of centralized bidding. The total amount of funds to be repurchased shall not be less than 100 million yuan and not more than 150 million yuan, and the repurchase price shall not exceed 15 yuan / share. It is intended to be used for the implementation of employee stock ownership plan, stock incentive or the conversion of convertible corporate bonds issued by Listed Companies in the future.
Hefei Fengle Seed Co.Ltd(000713) : it is proposed to invest 36 million yuan to hold Tianyu Xinghe
Hefei Fengle Seed Co.Ltd(000713) ( Hefei Fengle Seed Co.Ltd(000713) ) announcement: the company signed an agreement with Sichuan Tianyu Xinghe Biotechnology Co., Ltd. (hereinafter referred to as “Tianyu Xinghe”) and its shareholders to invest 36 million yuan in total to control Tianyu Xinghe by means of capital increase and equity transfer. A batch of breakthrough breeding materials created by Tianyu Xinghe can effectively solve the “neck” pain point of seed industry research and development. After the acquisition, the company will accelerate the enrichment and improvement of its core technology system and the transformation of achievements, that is, promote the industrialization of non transgenic molecular biology breeding with commercial seed breeding system.
Changjiangrunfa Health Industry Co.Ltd(002435) : the company and yanye have not carried out cooperation on covid-19 virus treatment drugs
Changjiangrunfa Health Industry Co.Ltd(002435) ( Changjiangrunfa Health Industry Co.Ltd(002435) ) announcement: the company is concerned about the recent rumors in the market about the cooperation between the company and covid-19 virus treatment drugs of yanyeyi pharmaceutical company. On relevant matters, the company suggests that at present, the company has reached cooperation with yanyeyi’s Changao Pharmaceutical Technology Group Co., Ltd. on “Lulit” luliconazole cream. As of the disclosure date of the announcement, the two sides have not carried out cooperation on covid-19 virus treatment drugs.
Fujian Cosunter Pharmaceutical Co.Ltd(300436) : hepatitis B treatment innovative medicine GST-HG141 clinical Ib phase test has positive results
Fujian Cosunter Pharmaceutical Co.Ltd(300436) ( Fujian Cosunter Pharmaceutical Co.Ltd(300436) ) announcement: GST-HG141, a new drug for hepatitis B treatment, has completed the Ib phase clinical trial. The results show that GST-HG141 has good safety, pharmacodynamics and pharmacokinetics for chronic hepatitis B patients in China. Its clinical Ib phase test has achieved positive results, and supports GST-HG141 to continue the II phase clinical trial.
Sinofibers Technology Co.Ltd(300777) : sign the order contract of carbon fiber and carbon fiber fabric of RMB 2.169 billion
Sinofibers Technology Co.Ltd(300777) ( Sinofibers Technology Co.Ltd(300777) ) announcement: Recently, the company signed a product order contract with customer a, the subject matter of which is carbon fiber and carbon fiber fabric, with a contract amount of RMB 2.169 billion, accounting for 556.94% of the audited operating revenue of the company in the latest fiscal year, and the contract performance period is from 2022 to 2023.
Anshan Hifichem Co.Ltd(300758) : it is proposed to repurchase shares of RMB 100 million to RMB 200 million
Anshan Hifichem Co.Ltd(300758) ( Anshan Hifichem Co.Ltd(300758) ) announcement: the company plans to buy back the company’s shares with its own funds in the form of centralized bidding transaction. The total capital of the repurchased shares shall not be less than 100 million yuan and not more than 200 million yuan. The price range of the repurchased shares shall not exceed 19.60 yuan / share. The repurchased shares will be used for the subsequent implementation of the employee stock ownership plan or equity incentive plan.
Zhongshan Broad-Ocean Motor Co.Ltd(002249) : it is proposed to repurchase shares with RMB 50 million to RMB 70 million
Zhongshan Broad-Ocean Motor Co.Ltd(002249) ( Zhongshan Broad-Ocean Motor Co.Ltd(002249) ) announcement: the company decided to buy back part of the public shares of the company through centralized bidding transaction with its own funds through the secondary market for subsequent employee stock ownership plans or equity incentive plans.
The total capital of this repurchase shall not be less than 50 million yuan and not more than 70 million yuan, and the repurchase price shall not exceed 7.5 yuan / share.
Annual performance report:
Luxshare Precision Industry Co.Ltd(002475) : net profit in 2021 decreased by 2.12% year on year
Luxshare Precision Industry Co.Ltd(002475) ( Luxshare Precision Industry Co.Ltd(002475) ) announcement: the operating revenue in 2021 was 154106 billion yuan, with a year-on-year increase of 66.60%; The net profit attributable to the parent company was 7.2 billion yuan, a year-on-year decrease of 1.22%; The basic earnings per share is 1.01 yuan.
Han nationality CNC: net profit in 2021 increased by 130.21% year-on-year
Han CNC (301200) announced that the company achieved an operating revenue of 4.081 billion yuan, an increase of 84.62% over the same period last year; The net profit was 699 million yuan, an increase of 130.21% over the same period last year; The basic earnings per share is 1.85 yuan.
Ganfeng Lithium Co.Ltd(002460) : net profit in 2021 increased by 405.03% year on year
Ganfeng Lithium Co.Ltd(002460) ( Ganfeng Lithium Co.Ltd(002460) ) announcement: the company achieved an operating revenue of 11.162 billion yuan, a year-on-year increase of 102.07%; The net profit was 5.175 billion yuan, a year-on-year increase of 405.03%; The basic earnings per share is 3.66 yuan.
